Project
GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for WRNIP1
Z-value: 2.01
Motif logo
Transcription factors associated with WRNIP1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
WRNIP1
|
ENSG00000124535.11 | WRN helicase interacting protein 1 |
Activity profile of WRNIP1 motif
Sorted Z-values of WRNIP1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of WRNIP1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 40.0 | 720.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 37.9 | 151.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 37.7 | 603.9 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 34.6 | 172.9 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 34.1 | 204.6 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 31.4 | 94.2 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 29.8 | 29.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 29.6 | 88.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 28.1 | 84.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 26.8 | 160.7 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 26.5 | 79.5 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 26.3 | 78.8 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 24.4 | 97.7 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 24.2 | 24.2 | GO:0007602 | phototransduction(GO:0007602) |
| 23.7 | 166.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 23.5 | 164.8 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
| 23.5 | 94.1 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 23.3 | 116.3 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 23.0 | 230.1 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 22.6 | 22.6 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 22.6 | 67.8 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 22.3 | 67.0 | GO:1902995 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 22.1 | 66.4 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 22.1 | 88.5 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 21.3 | 128.0 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 21.2 | 63.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 21.2 | 84.7 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 21.1 | 21.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 21.0 | 62.9 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
| 20.9 | 187.7 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 20.8 | 41.7 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
| 19.2 | 57.6 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 19.0 | 75.9 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 18.8 | 56.5 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 18.8 | 56.5 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 18.3 | 54.9 | GO:0014016 | neuroblast differentiation(GO:0014016) |
| 18.2 | 54.6 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 18.2 | 18.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 18.1 | 54.3 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 17.9 | 143.6 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
| 17.2 | 34.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 17.1 | 51.3 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 16.9 | 84.5 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 16.8 | 218.7 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 16.7 | 83.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 16.4 | 49.3 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 16.4 | 65.7 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 16.2 | 16.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
| 16.2 | 32.4 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 16.2 | 97.0 | GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 16.2 | 48.5 | GO:0035978 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 15.9 | 95.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 15.7 | 47.1 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 15.6 | 15.6 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
| 15.5 | 46.4 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 15.4 | 15.4 | GO:2001074 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 15.1 | 15.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 15.0 | 15.0 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
| 14.8 | 14.8 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) negative regulation of response to DNA damage stimulus(GO:2001021) |
| 14.6 | 43.7 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
| 14.5 | 57.9 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
| 14.5 | 57.9 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 14.4 | 14.4 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
| 14.4 | 86.6 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 14.4 | 115.2 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 14.3 | 43.0 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
| 14.2 | 56.8 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 14.1 | 28.1 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) nephrogenic mesenchyme morphogenesis(GO:0072134) |
| 14.0 | 41.9 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 13.9 | 41.8 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 13.8 | 193.1 | GO:0015671 | oxygen transport(GO:0015671) |
| 13.8 | 13.8 | GO:0046660 | female sex differentiation(GO:0046660) |
| 13.7 | 82.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 13.7 | 54.7 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 13.6 | 163.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 13.6 | 13.6 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 13.6 | 203.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 13.5 | 27.1 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 13.5 | 53.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 13.4 | 67.2 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 13.1 | 39.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 13.1 | 13.1 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 12.9 | 12.9 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 12.8 | 115.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 12.8 | 12.8 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 12.7 | 63.6 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 12.7 | 25.4 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 12.7 | 12.7 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 12.7 | 63.5 | GO:1901908 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 12.7 | 50.8 | GO:0019086 | late viral transcription(GO:0019086) |
| 12.6 | 37.9 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 12.5 | 37.6 | GO:0060915 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 12.5 | 50.0 | GO:0042335 | cuticle development(GO:0042335) |
| 12.4 | 62.0 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
| 12.4 | 37.1 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 12.3 | 110.9 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 12.3 | 49.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 12.2 | 73.4 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 12.1 | 48.5 | GO:0003185 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 12.1 | 24.2 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 12.1 | 48.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 12.0 | 60.0 | GO:0030070 | insulin processing(GO:0030070) |
| 12.0 | 48.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 12.0 | 35.9 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 12.0 | 71.8 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 12.0 | 35.9 | GO:0001207 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 12.0 | 71.7 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) |
| 12.0 | 167.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 11.9 | 35.8 | GO:1902363 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 11.8 | 11.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 11.8 | 118.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 11.8 | 47.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 11.8 | 47.3 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 11.8 | 23.6 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
| 11.8 | 11.8 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 11.8 | 47.1 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 11.8 | 47.1 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 11.7 | 58.7 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
| 11.7 | 35.0 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 11.6 | 46.5 | GO:1903949 | positive regulation of cardiac conduction(GO:1903781) positive regulation of atrial cardiac muscle cell action potential(GO:1903949) positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 11.6 | 11.6 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
| 11.5 | 34.6 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 11.5 | 11.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 11.5 | 22.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 11.4 | 45.6 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 11.4 | 57.0 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 11.4 | 466.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 11.3 | 22.7 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 11.3 | 11.3 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 11.2 | 56.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
| 11.2 | 22.3 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 11.1 | 22.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 11.1 | 144.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 11.1 | 44.2 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 11.0 | 32.9 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 10.9 | 32.8 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 10.9 | 54.5 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 10.8 | 54.2 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 10.8 | 21.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 10.8 | 53.8 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 10.7 | 10.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 10.7 | 10.7 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 10.7 | 32.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 10.7 | 42.8 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 10.7 | 21.4 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
| 10.7 | 53.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 10.6 | 42.5 | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 10.6 | 179.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 10.5 | 10.5 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 10.5 | 21.0 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 10.5 | 31.4 | GO:1904647 | response to rotenone(GO:1904647) |
| 10.5 | 41.8 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 10.4 | 10.4 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 10.4 | 62.6 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 10.4 | 83.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 10.4 | 20.7 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 10.4 | 62.1 | GO:0060613 | fat pad development(GO:0060613) |
| 10.3 | 10.3 | GO:0060594 | mammary gland specification(GO:0060594) |
| 10.3 | 30.9 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
| 10.3 | 10.3 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 10.2 | 10.2 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 10.2 | 10.2 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 10.2 | 40.8 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 10.2 | 30.6 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 10.1 | 81.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 10.1 | 30.4 | GO:1902565 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 10.0 | 20.0 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) |
| 10.0 | 49.9 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
| 10.0 | 79.8 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 10.0 | 39.9 | GO:0048749 | compound eye development(GO:0048749) |
| 9.9 | 29.8 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 9.9 | 79.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 9.9 | 9.9 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 9.9 | 9.9 | GO:0018307 | enzyme active site formation(GO:0018307) |
| 9.8 | 29.5 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 9.8 | 39.3 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 9.8 | 39.3 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 9.8 | 19.6 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 9.8 | 49.0 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 9.8 | 9.8 | GO:0006983 | ER overload response(GO:0006983) |
| 9.7 | 58.0 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 9.7 | 38.7 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 9.6 | 77.0 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 9.6 | 28.9 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 9.6 | 28.8 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 9.6 | 28.8 | GO:0008355 | olfactory learning(GO:0008355) |
| 9.6 | 19.1 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 9.5 | 66.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 9.5 | 133.0 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 9.5 | 47.3 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 9.4 | 28.3 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 9.4 | 46.8 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 9.4 | 18.7 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 9.3 | 56.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 9.3 | 46.6 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 9.3 | 27.8 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 9.2 | 18.5 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 9.2 | 18.3 | GO:0032526 | response to retinoic acid(GO:0032526) |
| 9.1 | 27.4 | GO:0050798 | activated T cell proliferation(GO:0050798) |
| 9.1 | 27.4 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 9.1 | 9.1 | GO:0015870 | acetylcholine transport(GO:0015870) |
| 9.1 | 99.8 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
| 9.0 | 18.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 9.0 | 45.0 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 9.0 | 45.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 8.9 | 8.9 | GO:0042710 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 8.9 | 44.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 8.9 | 17.8 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
| 8.9 | 62.3 | GO:0006562 | proline catabolic process(GO:0006562) |
| 8.9 | 26.7 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 8.9 | 26.6 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
| 8.9 | 17.7 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 8.9 | 26.6 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
| 8.9 | 26.6 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 8.8 | 35.3 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 8.8 | 35.2 | GO:0010157 | response to chlorate(GO:0010157) |
| 8.8 | 131.4 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 8.8 | 26.3 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 8.8 | 61.3 | GO:0045007 | depurination(GO:0045007) |
| 8.8 | 376.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 8.7 | 8.7 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) |
| 8.7 | 8.7 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 8.7 | 69.4 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
| 8.7 | 8.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 8.6 | 95.0 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 8.6 | 17.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 8.6 | 25.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 8.5 | 25.6 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 8.5 | 17.0 | GO:0007412 | axon target recognition(GO:0007412) |
| 8.5 | 203.4 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 8.4 | 33.7 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 8.4 | 8.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 8.4 | 25.2 | GO:0071529 | cementum mineralization(GO:0071529) |
| 8.4 | 75.5 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 8.3 | 24.9 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 8.3 | 49.6 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 8.3 | 41.3 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 8.2 | 24.7 | GO:1902809 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 8.2 | 16.4 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 8.2 | 32.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 8.2 | 40.9 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 8.2 | 40.8 | GO:1902075 | cellular response to salt(GO:1902075) |
| 8.1 | 8.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 8.1 | 89.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 8.1 | 16.1 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 8.0 | 32.1 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 8.0 | 32.1 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 8.0 | 48.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 8.0 | 8.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 8.0 | 55.7 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 7.9 | 55.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
| 7.9 | 31.7 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 7.9 | 23.7 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 7.9 | 31.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 7.9 | 23.6 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 7.9 | 39.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 7.8 | 7.8 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 7.8 | 54.8 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 7.8 | 85.8 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
| 7.8 | 31.2 | GO:0019046 | release from viral latency(GO:0019046) |
| 7.8 | 15.6 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 7.8 | 23.4 | GO:0100009 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 7.8 | 7.8 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 7.8 | 23.3 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 7.8 | 15.5 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 7.7 | 7.7 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
| 7.7 | 23.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 7.7 | 61.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 7.7 | 7.7 | GO:1990641 | response to iron ion starvation(GO:1990641) |
| 7.7 | 46.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 7.6 | 15.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 7.6 | 22.9 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
| 7.6 | 15.2 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 7.6 | 7.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 7.6 | 7.6 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 7.6 | 7.6 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 7.6 | 7.6 | GO:0014032 | neural crest cell migration(GO:0001755) neural crest cell development(GO:0014032) |
| 7.6 | 91.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 7.6 | 7.6 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 7.6 | 45.3 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
| 7.5 | 37.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 7.5 | 7.5 | GO:0010165 | response to X-ray(GO:0010165) |
| 7.5 | 7.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 7.5 | 45.1 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 7.5 | 7.5 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
| 7.5 | 67.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 7.5 | 37.5 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 7.5 | 37.4 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 7.5 | 44.8 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 7.5 | 22.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 7.4 | 29.8 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 7.4 | 22.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 7.4 | 22.3 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 7.4 | 66.7 | GO:0006477 | protein sulfation(GO:0006477) |
| 7.4 | 7.4 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation(GO:0030497) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) very long-chain fatty acid biosynthetic process(GO:0042761) |
| 7.3 | 51.4 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 7.3 | 36.7 | GO:1901523 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 7.3 | 7.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 7.3 | 29.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 7.2 | 21.7 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 7.2 | 7.2 | GO:0051885 | positive regulation of anagen(GO:0051885) |
| 7.2 | 21.6 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 7.2 | 35.9 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 7.2 | 14.3 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
| 7.2 | 21.5 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 7.2 | 21.5 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 7.2 | 57.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 7.1 | 7.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 7.1 | 21.3 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 7.1 | 21.3 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 7.1 | 7.1 | GO:0071878 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
| 7.1 | 7.1 | GO:0050863 | regulation of T cell activation(GO:0050863) |
| 7.1 | 7.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 7.1 | 98.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 7.1 | 56.5 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 7.1 | 14.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 7.0 | 14.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 7.0 | 7.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 7.0 | 7.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 7.0 | 63.0 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
| 7.0 | 21.0 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 7.0 | 14.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 7.0 | 20.9 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 7.0 | 20.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 7.0 | 20.9 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 7.0 | 180.7 | GO:0097503 | sialylation(GO:0097503) |
| 6.9 | 34.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 6.9 | 173.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 6.9 | 13.9 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 6.9 | 6.9 | GO:0046951 | cellular ketone body metabolic process(GO:0046950) ketone body biosynthetic process(GO:0046951) ketone body metabolic process(GO:1902224) |
| 6.9 | 48.2 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
| 6.9 | 13.8 | GO:0000187 | activation of MAPK activity(GO:0000187) |
| 6.9 | 6.9 | GO:2000366 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 6.8 | 6.8 | GO:0001743 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
| 6.8 | 6.8 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 6.8 | 27.3 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
| 6.8 | 27.2 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 6.8 | 20.4 | GO:0070142 | synaptic vesicle budding(GO:0070142) |
| 6.8 | 6.8 | GO:0009624 | response to nematode(GO:0009624) |
| 6.8 | 27.2 | GO:0070384 | Harderian gland development(GO:0070384) |
| 6.8 | 27.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 6.8 | 6.8 | GO:0007497 | posterior m |